Promote Scientific Collaboration
Access to Unique Applications and Tools
HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website is currently a joint development effort by CHDI and UCLA, through the laboratory of Dr. Giovanni Coppola. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Latest news and publications from around the HD Ecosystem
- Fresh Updates from First Huntingtin Lowering Study Publication
- An Updated Trial Design for Roche’s Huntingtin Lowering Trial
- When interrupting is good: genetic hiccups that protect against Huntington’s disease
- Huntington’s disease therapeutics conference 2019 – Day 3
- Huntington’s disease therapeutics conference 2019 – Day 2
- Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease.
- NEUROBIOLOGY OF VITAMIN C: EXPANDING THE FOCUS FROM ANTIOXIDANT TO ENDOGENOUS NEUROMODULATOR.
- The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome.
- Genetic cooperativity in multi-layer networks implicates cell survival and senescence in the striatum of Huntington’s disease mice synchronous to symptoms.
- Recent advances in molecular therapies for neurological disease: triplet repeat disorders.
- Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament …
- Cognito Therapeutics Announces Appointment of Dr. Mihály Hajós as Chief Scientific Officer
- New Outlay Invasive Brain Monitoring Device Market Is Showing Strong Growth by Leading …
- Global Brain Disease Market Size Growth Rate by Type (2019-2025)
- Global Brain Disease Market Share by Application (2019-2025)